-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2016 to Q3 2024.
- Oramed Pharmaceuticals Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1.13M.
- Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2022 was $100K.
- Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2019 was $300K.
- Oramed Pharmaceuticals Inc. annual Income Tax Expense (Benefit) for 2017 was $400K, a 70% decline from 2016.
Income Tax Expense (Benefit), Quarterly (USD)